These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
þ
|
Filed by the Registrant
|
¨
|
Filed by a Party other than the Registrant
|
CHECK THE APPROPRIATE BOX:
|
||
¨
|
|
Preliminary Proxy Statement
|
¨
|
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
þ
|
|
Definitive Proxy Statement
|
¨
|
|
Definitive Additional Materials
|
¨
|
|
Soliciting Material Pursuant to Section 240.14a-12
|
PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):
|
|||
þ
|
|
No fee required.
|
|
¨
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
1) Title of each class of securities to which transaction applies:
|
|
|
|
2) Aggregate number of securities to which transaction applies:
|
|
|
|
3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
4) Proposed maximum aggregate value of transaction:
|
|
|
|
5) Total fee paid:
|
¨
|
|
Fee paid previously with preliminary materials.
|
|
¨
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
|
|
|
|
|
1) Amount previously paid:
|
|
|
|
2) Form, Schedule or Registration Statement No.:
|
|
|
|
3) Filing Party:
|
|
|
|
4) Date Filed:
|
![]() |
|
IPG Photonics Corporation
|
|
2020 Annual Letter
|
|
Valentin P. Gapontsev, Ph.D.
Chairman and Chief Executive Officer
|
![]() |
To Our Stockholders,
|
|
Although 2019 proved to be a challenging year, we demonstrated good progress in a number of key growth initiatives. We delivered product cost reductions and differentiated new features and accessories for our core products. Furthermore, we are leveraging one of the largest R&D investments in the laser industry to launch leading edge laser products and systems for new markets to enhance our growth and margin profile and provide greater geographic and end market diversification.
The weaker global macroeconomic backdrop, US-China trade conflict and a more intense competitive landscape in China affected our 2019 financial performance. As a result of these challenges, we experienced a significant decrease in the average selling prices for our products in China, which reduced the dollar value of the laser cutting market. Although we shipped a record number of high power lasers, increasing laser units at 1 kilowatt or greater by 23%, achieving revenue growth was challenging. Despite this challenge, we continue to see customers in the laser cutting market adopt higher power solutions. We increased sales of lasers at 10 kilowatts or greater by more than 25%, even though the second half of the year was weaker for these ultra high power solutions.
|
![]() |
However, multiple IPG customers are launching new cutting systems using our 12 kilowatt lasers, and we increased sales of 20 kilowatt lasers for cutting applications 8-fold. Many of these are sold with our new ultra high power cutting heads. In addition, we sold our first lasers with high peak power (HPP) and adjustable mode beam (AMB) capability. HPP products deliver peak energy twice the average power of the laser, increasing cutting speed and quality while reducing scrap through closer nesting of parts. Our new AMB lasers permit the broadest range of beam tunability, enabling spatterless welding and enhancing the speed of electric vehicle battery production. When combined with our unique high power pulsed lasers for foil cutting and ultra high power continuous wave (CW) lasers for welding, we see significant opportunities in the electric vehicle battery market in 2020 and beyond.
Augmenting our laser solutions with high power optical heads is a key differentiator versus our laser competitors. In 2019, we delivered record sales of optical heads and other beam delivery accessories, growing sales of these products by 10%. We also shipped our first volume orders of our Laser Depth Dynamics (LDD) process monitoring systems, our patented real-time weld monitoring solution. LDD enables greater use of laser-based welding in automated production environments, and we are pursuing multiple million dollar plus opportunities with this technology and associated laser product sales.
Further, we sold a record number of systems for materials processing in 2019 with revenue increasing 33% excluding Genesis, acquired in December 2018. Standard and custom systems for vehicle and battery production, medical device manufacturing, pipe welding, cleaning and inspection applications drove systems growth. We plan to leverage Genesis’ expertise in robotic systems integration to accelerate laser processing within the transportation, aerospace and industrial end markets.
|
Product innovation remains core to our success and the source of growth over the coming years. In 2019, new product sales were 19% of total revenue and 24% in the fourth quarter alone. Sales of green pulsed lasers used to improve solar cell efficiency increased by more than 60% in 2019. Sales of ultrafast pulsed lasers increased more than 80% year over year off a small base, with more than 50 new projects for these lasers across a wide range of applications processing glass, ceramics, circuit boards, OLED film, batteries and solar cells. We plan to enhance the pulse energy and expand the portfolio of new green, ultraviolet and ultrafast pulsed lasers to increase our available markets.
|
|
Sales of medical lasers increased 80% in 2019 as our fiber laser-based system solution received approvals in China and the US. We expect sales into urology and other soft tissue applications to ramp over the coming years off a low base. Our lithotripsy medical laser application uses consumable fibers, which have the potential to develop into a more meaningful recurring revenue stream as the number of installed systems increases. We continue to invest in transformative new products for new application areas as well, including new medical treatments, mid-infrared lasers for spectroscopy, inspection and sensing applications, and ultra high power single mode lasers for aerospace and defense.
We have one of the strongest balance sheets in the industrial automation industry, with more than $1 billion net cash and ample liquidity. This strength allows us to prioritize R&D investments and capital expenditures focusing on long-term objectives - diversifying our business with new products, finding new markets and driving innovations to maintain and increase margins. In 2019, we spent $130 million on research and development and $134 million on capital expenditures for these purposes. In addition, we repurchased $41 million worth of stock and have offset all dilution from employee equity compensation since our anti-dilutive repurchase program began in July 2016.
|
![]() |
We believe we have significant long-term growth opportunities in laser welding, fine processing of electric vehicle batteries and our portfolio of new products addressing opportunities in micro processing, medical, systems and beam delivery solutions. Within our core business, we believe there is no company that can deliver high power laser solutions at our quality, scale, cost and lead time. We will rely on our core scientific strengths to optimize investment in strategic initiatives critical to the long-term success of the Company, enabling IPG to deliver strong growth in revenue and cash flow.
I want to thank our talented employees for their hard work during a difficult year. I would also like to thank you, our stockholders, for your loyalty and support. As ever, I remain confident in our ability to execute during this more challenging period and deliver on our mission to make our fiber laser technology the tool of choice in mass production.
|
|
![]() |
|
VALENTIN P. GAPONTSEV, PH.D.
Chairman and Chief Executive Officer
April 1, 2020
|
|
![]() |
![]() |
![]() |
DATE AND TIME
May 28, 2020
10:00 AM (Eastern Time) |
LOCATION
IPG Photonics Corporation
50 Old Webster Road Oxford, Massachusetts 01540 |
WHO CAN VOTE
Only stockholders of record at the
close of business on April 1, 2020 may vote at the Annual Meeting |
Proposals
|
Board Vote Recommendation
|
For Further Details
|
||
1
|
Election of nine directors named in this proxy statement
|
ü
FOR
each director nominee
|
![]() |
Page
12
|
2
|
Advisory approval of our executive compensation
|
ü
FOR
|
![]() |
Page
37
|
3
|
Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2020
|
ü
FOR
|
![]() |
Page
58
|
4
|
A stockholder proposal, if properly presented at the Annual Meeting
|
û
AGAINST
|
![]() |
Page
61
|
![]() |
![]() |
![]() |
INTERNET
Go to www.investorvote.com/ipgp
or scan the QR code contained
in the attached proxy card
|
TELEPHONE
1-800-652-VOTE (8683)
|
MAIL
Mark, sign, date and promptly
mail the enclosed proxy card in the postage-paid envelope |
|
As permitted by the rules of the United States Securities and Exchange Commission (the “SEC”), we are making this Proxy Statement and Annual Report on Form 10-K available to stockholders electronically via the Internet at investor.ipgphotonics.com. On or about April 9, 2020, we will mail to most of our stockholders a notice (the “Notice”) containing instructions on how to access this Proxy Statement and our Annual Report and to vote via the Internet or by telephone. Other stockholders, in accordance with their prior requests, will receive e-mail notification of how to access our proxy materials and vote via the Internet or by telephone, or will be mailed paper copies of our proxy materials and a proxy card on or about April 9, 2020.
|
|
Company Overview
|
Performance Highlights
|
NET SALES
|
OPERATING INCOME
|
![]() |
![]() |
|
* Excluding extraordinary charges related to impairment of goodwill and other long-lived assets and restructuring.
|
•
|
Shipped a record number of high power lasers and increased sales of lasers at 10 kilowatts or greater by more than 25%
|
•
|
Given weaker industrial demand trends resulting from escalation of the US-China trade conflict and macroeconomic challenges in our largest regions, revenue in 2019 decreased by 10%
|
•
|
As we enhance our capability in providing complete laser solutions to end customers, we sold a record number of laser systems for materials processing in 2019
|
•
|
We are leveraging one of the largest R&D investments in the laser industry to launch leading edge products, and in 2019 new product sales were 19% of total revenue
|
•
|
Because of lower absorption of fixed costs in our vertically-integrated business model, lower product pricing, foreign exchange headwinds and other factors, our industry-leading gross margin declined to 46%
|
•
|
We delivered operating cash flow of $324 million
|
•
|
We have one of the strongest balance sheets in the industrial automation industry, with more than $1 billion net cash and ample liquidity at December 31, 2019
|
Voting Items
|
|
||
Proposal
1 |
Election of Nine Directors
The Board recommends a vote
FOR
each director nominee named in this Proxy Statement.
|
|
![]() |
See page
12
|
|
|
|
|
|
|
|
|
Committee Membership
|
||
|
Name and Principal Occupation
|
Age
|
Director Since
|
AC
|
CC
|
NCGC
|
![]() |
Valentin P. Gapontsev, Ph.D.
|
|
|
|
|
|
Chief Executive Officer and Chairman of the Board
|
81
|
1998
|
|
|
|
|
![]() |
Eugene A. Scherbakov, Ph.D.
|
|
|
|
|
|
Chief Operating Officer
Managing Director, IPG Laser GmbH
|
72
|
2000
|
|
|
|
|
![]() |
Igor Samartsev
|
|
|
|
|
|
Chief Technology Officer
|
57
|
2006
|
|
|
|
|
![]() |
Michael C. Child
IND
|
|
|
|
|
|
Senior Advisor, T.A. Associates, Inc.
|
65
|
2000
|
|
|
●
|
|
![]() |
Gregory P. Dougherty
IND
|
|
|
|
|
|
Former CEO, Oclaro, Inc.
|
60
|
2019
|
●
|
●
|
|
|
![]() |
Catherine P. Lego
IND
|
|
|
|
|
|
Professional board director
|
63
|
2016
|
●
|
●
|
|
|
![]() |
Eric Meurice
IND
|
|
|
|
|
|
Former President, CEO and Chairman, ASML Holding NV
|
63
|
2014
|
|
●
|
●
|
|
![]() |
John R. Peeler
Presiding Independent Director
|
|
|
|
|
|
Chairman, Veeco Instruments, Inc.
|
65
|
2012
|
|
●
|
●
|
|
![]() |
Thomas J. Seifert
IND
|
|
|
|
|
|
Chief Financial Officer, Cloudflare, Inc.
|
56
|
2014
|
●
|
|
●
|
AC
Audit Committee
|
●
|
Chair
|
CC
Compensation Committee
|
●
|
Member
|
NCGC
Nominating and Corporate Governance Committee
|
|
|
DIRECTOR
INDEPENDENCE |
BALANCED TENURE
|
AGE
|
DIVERSITY
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
6/9
directors
are independent** |
11 years
Average Tenure
|
65 years
Average Age
|
Over 50%
Diverse
|
|
|
|
|
*
|
Following the Annual Meeting
|
**
|
Audit, Compensation and Nominating and Corporate Governance Committees are composed entirely of independent directors
|
![]() |
Lasers and
Technology |
![]() |
|
![]() |
Business
Development and M&A |
![]() |
![]() |
Financial
Literacy |
![]() |
|
![]() |
Risk
Management |
![]() |
![]() |
Global
Business |
![]() |
|
![]() |
Executive
Leadership |
![]() |
![]() |
Manufacturing
and Operating |
![]() |
|
![]() |
Other Public
Company Boards |
![]() |
*
|
Following the Annual Meeting
|
|
|
|
ü
Stockholder proxy access right adopted in March 2019
ü
Director majority voting policy adopted October 2018
ü
Ongoing Board refreshment: 1 independent director added in 2019, for a total of 2 directors added in 4 prior fiscal years
ü
Supermajority of independent directors and 100% independent Board committees
|
ü
55% of Board members come from internationally diverse backgrounds
ü
11% of Board members are women
ü
Presiding independent director
ü
Single class of voting stock and no supermajority voting provisions
ü
Annual election of all directors
ü
Stockholder right to act by written consent
|
ü
80% of director compensation at risk based upon stock performance
ü
Annual Board performance evaluations
ü
Robust director and executive officer stock ownership guidelines
ü
Anti-hedging policy applicable to all employees and directors
ü
Stockholder right to act by written consent
|
|
|
|
|
||
Proposal
2 |
Advisory Approval of Our Executive Compensation
The Board recommends a vote
FOR
this proposal.
|
|
![]() |
See page
37
|
|
|
|
|
|
Fixed
|
|
|
At-risk
|
|
|
|
|
|
Base Salary
|
|
Annual Cash Incentive
|
|
Long-Term Equity Incentives
|
|||
Target Mix
|
CEO*
|
OTHER NEOs
(Average)
|
|
CEO
|
OTHER NEOs
(Average)
|
|
OTHER NEOs
(Average)
|
|
|
![]() |
![]() |
|
![]() |
![]() |
|
![]() |
![]() |
|
* CEO receives no equity awards
|
|
|
|
|
|
Performance
based RSUs |
Service based
Equity Award |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance
|
•
Executive base salaries were not increased for 2019 in light of the challenging macro-economic environment facing the Company
|
|
•
Financial performance fell short of minimum revenue and earnings thresholds in 2019, resulting in no annual incentive payout based on financial performance
•
Individual performance awards were earned for managing through challenging business conditions
|
|
•
Type and proportion of equity grants reflected a 2019 review by our Compensation Committee with the assistance of our independent compensation consultant of grant practices at peer companies
•
Our CEO, as the founder and a significant stockholder, has not received an equity award since the Company’s 2006 IPO, resulting in lower compensation expenses and equity burn rate
|
|||
|
|
|
|
|
|
|||
Objective
|
•
Provide a competitive fixed component to attract and retain talented and experienced executives
|
|
•
Variable cash compensation opportunity is based upon annual net sales and profitability against threshold, target and maximum performance goals
•
Additional compensation opportunities are based upon individual performance
|
|
•
Align interests of our executives and stockholders by motivating executive officers to increase long-term stockholder value
•
Service-based equity awards vest over four years providing long-term retention and additional compensation opportunity for stock price increases
•
PSU awards provide additional incentives and are earned based on IPG’s total stockholder return relative to a comparable stock index
|
|||
|
|
|
|
|
|
|
|
|
•
Annual cash incentive payouts are capped and have challenging performance goals linked to key financial performance metrics
•
Long-term equity incentives are aligned with long-term stockholder value creation
•
Approximately 78% of non-CEO compensation in 2019 was at risk based on performance
•
Executives exceed stock ownership guidelines, aligning with interests of stockholders
|
![]() |
Say-on-pay approval
during last stockholder vote in 2017 |
Governance Features of Our
Executive Compensation Program |
|
|
|
PRACTICES WE EMPLOY
|
|
PRACTICES WE AVOID
|
|
|
|
ü
Align our officer pay with performance
ü
Balance annual and long-term incentives
ü
Use long-term incentives to link executive pay to company performance
ü
Cap on incentive award payouts
ü
Maximize stockholder value while mitigating risk
ü
Independent compensation consultant
ü
Robust stock ownership requirements
ü
Clawbacks on executive compensation
|
|
û
No guaranteed annual bonuses
û
No retirement benefits
û
No tax gross-ups
û
No significant perquisites
û
Hedging of Company stock is prohibited
û
No severance for “cause” terminations
û
No single-trigger change in control provisions
û
No stock option repricing without stockholder approval
û
Pledging of Company stock is limited
|
|
||
Proposal
3 |
Ratify Deloitte & Touche LLP as our Independent
Registered Public Accounting Firm for 2020
The Board recommends a vote
FOR
this proposal.
|
|
![]() |
See page
58
|
|
|
|
|
|
Fees
|
|||||
Fee Category
|
2019
|
|
2018
|
|
||
Audit fees
|
$
|
2,440,990
|
|
$
|
2,051,757
|
|
Audit-related fees
|
—
|
|
170,470
|
|
||
Tax fees
|
90,000
|
|
111,000
|
|
||
All other fees
|
—
|
|
—
|
|
||
Total Fees
|
$
|
2,530,990
|
|
$
|
2,333,227
|
|
|
||
Proposal
4 |
Stockholder Proposal to Prepare a Report on Management Team Diversity
The Board recommends a vote
AGAINST
the stockholder proposal to be presented at the meeting.
|
|
![]() |
See page
61
|
|
|
|
|
|
Page
|
2020 ANNUAL LETTER
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROPOSAL 4: STOCKHOLDER PROPOSAL TO PREPARE A REPORT ON
MANAGEMENT TEAM DIVERSITY
|
|
|
|
|
This Proxy Statement contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Proxy Statement except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in the section titled “Risk Factors” and elsewhere in our Annual Report and other filings with the SEC. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
|
|
|
||
Proposal
1 |
Election of Nine Directors
The Board of Directors recommends a vote
FOR
each director nominee named in this Proxy Statement.
|
|
|
|
|
|
|
|
Director Qualifications
|
|
|
|
|
|
![]() |
|
Lasers and Technology
|
|
We have sought directors with management and operational experience in the industries in which we compete. For example, last year we added a director with expertise in optical and electronics components, and telecommunications products. As a diversified technology, science-based company, directors with technology backgrounds understand the Company’s technology platforms and the importance of investing in new technologies for future growth.
|
|
![]() |
|
||
![]() |
|
Financial Literacy
|
|
Knowledge of finance or financial reporting; experience with debt/capital market transactions and/or mergers and acquisitions strengthen the Board’s oversight of financial reporting and internal controls. Financial metrics are used to measure our performance. All directors must understand finance and financial reporting processes. Two of the Audit Committee members qualify as “audit committee financial experts.”
|
|
![]() |
|
||
![]() |
|
Global Business
|
|
Global business experience is critical to the Company’s international operations and growth with 79% of sales from outside the U.S. in 2019. Knowledge of Asian and European business practices are valuable to understanding our business and strategy.
|
|
![]() |
|
||
![]() |
|
Manufacturing
and Operating |
|
As a vertically-integrated company, manufacturing experience and customer service on a global scale are important to understanding the operations and capital needs of the Company.
|
|
![]() |
|
![]() |
|
Business Development
and M&A |
|
We have used and will continue to use acquisitions to achieve our strategic goals. Directors with experience in business development and mergers and acquisitions provide valuable perspectives regarding process, due diligence, risk assessment and integration of potential partners.
|
|
![]() |
|
||
![]() |
|
Risk Management
|
|
In light of the Board’s role in overseeing risk management and understanding the most significant risks facing the Company, including cybersecurity risk, we continue to require directors with experience in risk management and oversight.
|
|
![]() |
|
||
![]() |
|
Executive Leadership
|
|
Significant leadership experience, including services as a CEO, senior executive, division president or functional leader within a complex organization enhances the Board’s leadership role.
|
|
![]() |
|
||
![]() |
|
Other Public Company Boards
|
|
Directors with current or recent membership on other public company boards provide valuable perspectives in many areas including operations, strategy, governance and compensation.
|
|
![]() |
|
||
|
|
|
|
|
|
|
Gapontsev
|
Scherbakov
|
Samartsev
|
Child
|
Dougherty
|
Lego
|
Meurice
|
Peeler
|
Seifert
|
Skills and Expertise
|
||||||||||
![]() |
Lasers and Technology
|
●
|
●
|
●
|
|
●
|
|
●
|
●
|
|
![]() |
Financial Literacy
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
![]() |
Global Business
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
![]() |
Manufacturing
and Operating |
●
|
●
|
|
●
|
●
|
|
●
|
●
|
●
|
![]() |
Business Development
and M&A |
●
|
●
|
|
●
|
●
|
●
|
●
|
●
|
●
|
![]() |
Risk Management
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
●
|
![]() |
Executive Leadership
|
●
|
●
|
●
|
|
●
|
|
●
|
●
|
●
|
![]() |
Other Public
Company Boards |
|
|
|
●
|
●
|
●
|
●
|
●
|
●
|
Background
|
||||||||||
|
Years on Board
|
22
|
20
|
14
|
20
|
1
|
4
|
6
|
8
|
6
|
|
Age
|
81
|
72
|
57
|
65
|
60
|
63
|
63
|
65
|
56
|
|
Gender
|
M
|
M
|
M
|
M
|
M
|
F
|
M
|
M
|
M
|
|
Internationally Diverse
|
●
|
●
|
●
|
|
|
|
●
|
|
●
|
Director Nominees
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Dr. Gapontsev has been the CEO and Chairman of the Board of IPG since our inception. Prior to founding the Company's predecessor in 1990, Dr. Gapontsev served as senior scientist in laser material physics and head of the laboratory at the Soviet Academy of Science’s Institute of Radio Engineering and Electronics in Moscow. In 2006, he was awarded the Ernst & Young® Entrepreneur of the Year Award for Industrial Products and Services in New England and in 2009, he was awarded the Arthur L. Schawlow Award by the Laser Institute of America. In 2011, he received the Russian Federation National Award in Science and Technology, and he was selected as a Fellow of the Optical Society of America. Dr. Gapontsev holds a Ph.D. in Laser Materials from the Moscow Institute of Physics and Technology.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Dr. Gapontsev is the founder of the Company and has successfully led the Company and the Board since the Company was formed to now. In the roles of CEO and Chairman of the Board, he has been responsible for formulation and execution of IPG’s strategy and providing leadership and oversight of IPG’s business during a period of rapid and profitable growth, as well as business contractions. He has over thirty years of academic research experience in the fields of solid state laser materials, laser spectroscopy and non-radiative energy transfer between rare earth ions and is the author of many scientific publications and several international patents. His strategic foresight and entrepreneurial spirit along with his deep scientific understanding has guided the Company’s continued growth and technology leadership.
|
|||||||
AGE:
81
DIRECTOR SINCE:
1998
COMMITTEES:
None
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
Lasers and Technology
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Executive
Leadership |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Dr. Scherbakov has served as Chief Operating Officer since February 2017, Managing Director of IPG Laser GmbH, our German subsidiary, since August 2000 and Senior Vice President-Europe since 2013. He served as the Technical Director of IPG Laser from 1995 to August 2000. From 1983 to 1995, Dr. Scherbakov was a senior scientist in fiber optics and head of the optical communications laboratory at the General Physics Institute, Russian Academy of Science in Moscow. Dr. Scherbakov graduated from the Moscow Physics and Technology Institute with an M.S. in Physics. In addition, Dr. Scherbakov attended the Russian Academy of Science in Moscow, where he received a Ph.D. in Quantum Electronics from its Lebedev Physics Institute and a Dr.Sci. degree in Laser Physics from its General Physics Institute.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Dr. Scherbakov has extensive knowledge of the Company’s business as Managing Director of IPG Laser GmbH, which produces a large volume of our products and is the source of many developments in products, technology and applications. He applies his knowledge and experience across our many international branches. The leadership and operational expertise of Dr. Scherbakov have contributed to IPG increasing production, lowering manufacturing costs, managing risk and maintaining high margins compared to our industry peers. He also has extensive technological knowledge of fiber lasers, their components and manufacturing processes. His service as an executive officer of the Company provides the Board with a detailed understanding of the Company’s operations, sales and customers.
|
|||||||
AGE:
72
DIRECTOR SINCE:
2000
COMMITTEES:
None
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
Lasers and Technology
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Executive
Leadership |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Since 2011, Mr. Samartsev has served as our Chief Technology Officer. Prior to that time, he served in management and technical leadership roles at NTO IRE-Polus, our subsidiary in Russia. Mr. Samartsev holds an M.S. in Physics from the Moscow Institute of Physics and Technology.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Mr. Samartsev is one of the founders of the Company and has a significant management role in the Company as Chief Technology Officer. As one of the key developers of the technology platform of the Company and leader in the development of many new optical technologies, components and products spanning our global development centers that form part of the Company’s strategic plan, the Board values Mr. Samartsev’s understanding of technology developments at our company.
|
|||||||
AGE:
57
DIRECTOR SINCE:
2006
COMMITTEES:
None
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
|
|
Lasers and Technology
|
Financial Literacy
|
Global
Business |
Risk
Management |
Executive
Leadership |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Since July 1982, Mr. Child has been employed by TA Associates, Inc., a private equity investment firm, where he currently serves as Senior Advisor and, prior to January 2011, he was Managing Director. Mr. Child holds a B.S. in Electrical Engineering from the University of California at Davis and an M.B.A. from the Stanford University Graduate School of Business. From September 2011 until December 2015, Mr. Child was a Lecturer at the Stanford University Graduate School of Business.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Mr. Child is an established and experienced investor, including in technology companies, from his three decades of experience at TA Associates, Inc. Over the course of his career, he has overseen numerous investments and sales of portfolio companies, and served on the boards of many public and private companies. Through his experiences, he has gained valuable knowledge in the management, operations and finance of technology growth companies.
|
|||||||
AGE:
65
DIRECTOR SINCE:
2000
COMMITTEES:
NCGC
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Other Public
Company Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Mr. Dougherty served as Chief Executive Officer of Oclaro, Inc., a maker of optical components and modules for the long-haul, metro and data center markets, from June 2013 and has served as a director of Oclaro from April 2009, until its December 2018 acquisition. Prior to Oclaro, Mr. Dougherty served as a director of Avanex Corporation (“Avanex”), a leading global provider of intelligent photonic solutions, from April 2005 to April 2009. Mr. Dougherty also served as a director of Picarro, Inc., a manufacturer of ultra-sensitive gas spectroscopy equipment using laser-based technology, from October 2002 to August 2013, and as its Interim Chief Executive Officer from January 2003 to April 2004. From February 2001 until September 2002, Mr. Dougherty was the Chief Operating Officer at JDS Uniphase Corporation (“JDS”), an optical technology company. Prior to JDS he was the Chief Operating Officer of SDL, Inc., a maker of laser diodes, from March 1997 to February 2001 when they were acquired by JDS. Mr. Dougherty serves on the boards of directors of Infinera Corporation, a provider of optical transport networking equipment, software and services to telecommunications service providers and others, since January 2019, Fabrinet, a provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to OEMs of complex products, since February 2019, and MaxLinear, Inc., a provider of radio frequency (RF), analog and mixed-signal integrated circuits, since March 2020. Mr. Dougherty earned a B.S. in optics from the University of Rochester.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Mr. Dougherty contributes to the Board significant leadership, operations, sales, marketing and general management experience in optics and components for telecommunications and other applications. For over three decades, Mr. Dougherty has worked in the optical and components industry and can provide the Board with insight into the industry and conditions in which the Company operates. Having been recently a CEO at a publicly-held company, he is familiar with a large range of management, corporate and board responsibilities and brings valuable perspectives to the Board as an independent director.
|
|||||||
AGE:
60
DIRECTOR SINCE:
2019
COMMITTEES:
Audit Committee, Compensation Committee
DIRECTORSHIP AT OTHER PUBLIC COMPANY:
Infinera Corporation, Fabrinet and MaxLinear, Inc.
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
Lasers and Technology
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Executive
Leadership |
Other Public
Company Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Ms. Lego is a professional board member and also provides consulting services to early-stage technology companies. From 1999 to 2009, Ms. Lego served as the general partner of The Photonics Fund, LLP, a venture capital investment firm focused on early stage investing in component, module and systems companies in the fiber optic telecommunications market. She served as the director of finance and investment analyst at Oak Investment Partners from 1981 to 1984, and as a general partner from 1985 to 1992. Ms. Lego serves on the boards of directors of Lam Research Corporation, a semiconductor equipment company, Cypress Semiconductor Corporation, a maker of microcontrollers, integrated circuits and memory devices and Guidewire Software, Inc., a provider of a technology platform for the property and casualty insurance industry. Ms. Lego holds a B.A. in Economics and Biology from Williams College and an M.S. in Accounting from the New York University Stern Graduate School of Business.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Ms. Lego has extensive experience working with advanced technology and semiconductor companies. From her current and prior service on the boards of several technology companies as well as her memberships of other audit, compensation and nominating and corporate governance committees, she is familiar with the issues faced and the processes that boards use to manage growth, risk, accounting, acquisitions, due diligence and integration, compensation and investor relations. In addition, she is a frequent speaker on board governance, ethics and audit quality at directors’ colleges and events, including the E&Y Tapestry and KPMG audit committee round tables. Ms. Lego is a member of the NACD’s Audit Committee Advisory Council. She brings valuable perspectives on the latest developments in audit, compensation and other matters to the Board.
|
|||||||
AGE:
63
DIRECTOR SINCE:
2016
COMMITTEES:
Audit Committee - Audit Committee
Financial Expert, Compensation Committee (Chair)
DIRECTORSHIP AT OTHER PUBLIC COMPANY:
Lam Research
Corporation, Cypress Semiconductor Corporation and Guidewire Software, Inc. |
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
|
|
Financial Literacy
|
Global
Business |
Business
Development and M&A |
Risk
Management |
Other Public
Company Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Mr. Meurice was President and Chief Executive Officer of ASML Holding NV, a provider of semiconductor manufacturing equipment and technology, from October 2004 to June 2013, and Chairman until March 2014. From 2001 to 2004, he was Executive Vice President of the Thomson Television Division of Thomson, SA, an electronics manufacturer. From 1995 to 2001, he served as head of Dell Computer’s Western, Eastern Europe and EMEA emerging market businesses. Before 1995, he gained significant technology experience at ITT Semiconductors and at Intel Corporation. Mr. Meurice previously served on the boards of Verigy Ltd., a manufacturer of semiconductor test equipment, ARM Holdings plc, a semiconductor intellectual property supplier, NXP Semiconductors N.V., a semiconductor company, and Meyer Burger Technology AG, a solar equipment vendor. Mr. Meurice serves on the boards of UMICORE S.A., a recycling and materials company, since April 2015, and SOITEC S.A., a semiconductor materials manufacturer, since July 2018, and where he was appointed Chairman since March 2019. Mr. Meurice earned a Master’s degree in Mechanics and Energy Generation at the Ecole Centrale de Paris, a Master’s degree in Economics from la Sorbonne University, Paris, and an M.B.A. from the Stanford University Graduate School of Business.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Mr. Meurice has extensive skills and experience as a manager of several rapidly-growing, complex and global businesses in the capital equipment and electronics fields with several billions of dollars in revenues, most recently as former President and Chief Executive Officer of ASML Holding NV. He has experience managing a publicly-held company as well as experience on serving on several public company boards in the equipment and technology fields. Mr. Meurice also has a record of proven leadership as a strategic thinker, operator and marketer at the businesses he managed.
|
|||||||
AGE:
63
DIRECTOR SINCE:
2014
COMMITTEES:
NCGC (Chair), Compensation Committee
DIRECTORSHIP AT OTHER PUBLIC COMPANY:
UMICORE S.A. and SOITEC S.A.
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
Lasers and Technology
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Executive
Leadership |
Other Public
Company Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Mr. Peeler was Chief Executive Officer of Veeco Instruments Inc. (“Veeco”) from July 2007 until September 2018, and Chairman or Executive Chairman of its board of directors from May 2012 until May 2020. Veeco is a developer and manufacturer of MOCVD, molecular beam epitaxy, ion beam and other advanced thin film processes equipment. He was Executive Vice President of JDS and President of the Communications Test & Measurement Group of JDS, which he joined upon the closing of JDS’s merger with Acterna, Inc. in August 2005. Before joining JDS, Mr. Peeler served as President and Chief Executive Officer of Acterna. He has a B.S. and M.E. in Electrical Engineering from the University of Virginia.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Over the course of his career, Mr. Peeler has managed several high-growth technology companies. In addition, he has developed managerial leadership skills through his former position as Chief Executive Officer of Veeco, a publicly-traded company with substantial international operations. His managerial positions have provided him with in-depth knowledge of the service needs of customers in demanding markets, including semiconductor capital equipment, various manufacturing models, marketing and sales. In these roles, he has also been responsible for attracting and incentivizing executives on his team. These experiences have provided him important insights in support of his positions as Presiding Independent Director and a member of the Compensation Committee and the NCGC.
|
|||||||
AGE:
65
DIRECTOR SINCE:
2012
COMMITTEES:
Compensation
Committee, NCGC
DIRECTORSHIP AT OTHER PUBLIC COMPANY:
Veeco Instruments Inc.
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
Lasers and Technology
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Executive
Leadership |
Other Public
Company Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
Mr. Seifert is Chief Financial Officer of Cloudflare, Inc., an internet performance and security provider, from June 2017 to the present. Since February 2018, he is a member of the board of CompuGroup Medical SE, a publicly held company in Germany, which provides software to support medical and organization activities in medical offices and facilities. Mr. Seifert was the Executive Vice President and Chief Financial Officer of Symantec Corporation, a provider of security, backup and availability solutions, from March 2014 to December 2016. Mr. Seifert served as Executive Vice President and Chief Financial Officer of Brightstar Corporation, a wireless distribution and services company, from December 2012 to March 2014. He was Senior Vice President and Chief Financial Officer at Advanced Micro Devices Inc., a semiconductor company, from October 2009 to August 2012, and served as Interim Chief Executive Officer from January 2011 to September 2012. From October 2008 to August 2009, Mr. Seifert served as Chief Operating Officer and Chief Financial Officer of Qimonda AG, a German memory chip manufacturer, and as Chief Operating Officer from June 2004 to October 2008. He also held executive positions at Infineon AG, White Oak Semiconductor, including the position as Chief Executive Officer, and Altis Semiconductor. Mr. Seifert has a Bachelor’s degree and a Master’s degree in Business Administration from Friedrich Alexander University and a Master’s degree in Mathematics and Economics from Wayne State University.
KEY ATTRIBUTES, EXPERIENCE AND SKILLS
Mr. Seifert has extensive experience as both an operating executive and chief financial officer of large publicly-held international technology businesses, such as Symantec and Advanced Micro Devices. In these and other senior positions, he developed deep financial and accounting knowledge, as well as managerial leadership skills, in larger organizations. With his background in accounting, finance and management, Mr. Seifert brings broad skills and knowledge to the Board, the Audit Committee, and the NCGC including internal controls, mergers and acquisitions, integrations and information technology security.
|
|||||||
AGE:
56
DIRECTOR SINCE:
2014
COMMITTEES:
Audit Committee
(Chair) - Audit Committee Financial Expert, NCGC
DIRECTORSHIP AT OTHER PUBLIC COMPANY:
CompuGroup
Medical, SE |
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
|
Financial Literacy
|
Global
Business |
Manufacturing
and Operating |
Business
Development and M&A |
Risk
Management |
Executive
Leadership |
Other Public
Company Boards |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends that you vote
FOR
each director nominee named in this Proxy Statement.
|
|
Board Refreshment and Composition
|
•
|
Thoughtful, Deliberate Board Refreshment Process.
The Board’s refreshment actions reflect a thoughtful and deliberate process that was informed by our Company’s strategic needs as well as the Board’s annual self-assessment and director nomination processes.
|
•
|
Appropriately Balance Experience and Perspectives While Ensuring an Orderly Transition.
Our Board has taken care as part of its Board refreshment process to appropriately balance new perspectives and the experience of existing directors while undergoing an orderly transition of roles and responsibilities on the Board and its committees.
|
•
|
Importance of Board Diversity.
In addition, our Board continues to focus on the importance of Board diversity. One of the two new directors who joined our Board since 2016 is female. Gender diverse candidates have been and are included in our board searches.
|
|
DIRECTOR TENURE AND RETIREMENT AGE POLICIES
• No Term Limits; Appropriate Balance of Skills, Knowledge, Experience and Perspectives.
• Our Board recognizes the importance of periodic Board refreshment and maintaining an appropriate balance of tenure, experience and perspectives on the Board.
• We believe it is desirable to maintain a mix of longer-tenured, experienced directors with institutional memory and understanding of our business and culture and newer directors with fresh perspectives. However, we do not impose director tenure limits.
• The Board believes that directors should not have an expectation of being renominated annually and that the NCGC’s assessment is a key component of its director nomination process.
• In connection with the Board’s annual self-assessment and director nomination processes, the Board considers upcoming retirements, the average tenure and overall mix of individual director tenures of the Board, the overall mix of the skills, knowledge, experience and diversity, each individual director’s performance and contributions to the work of the Board and its committees, the personal circumstances and other time commitments of directors, along with other factors the Board deems appropriate.
• The Board believes that, as an alternative to term limits, non-management directors should submit their resignation from the Board upon attaining the age of 72 and on each subsequent anniversary. The Board then considers the needs and circumstances confronting the Board and, upon recommendation of the NCGC, determines whether to accept or decline the resignation.
• Our Board’s age resignation policy is intended to facilitate our Board’s recruitment of new directors with appropriate skills, experience and backgrounds and provide for an orderly transition of leadership on our Board.
|
|
|
|
|
|
|
|
|
1
|
![]() |
2
|
![]() |
3
|
![]() |
4
|
EVALUATION OF
BOARD COMPOSITION |
|
IDENTIFICATION OF POOL OF CANDIDATES
|
|
MEETINGS WITH
POTENTIAL CANDIDATES |
|
RECOMMENDATION OF
POTENTIAL DIRECTORS FOR APPROVAL |
•
The NCGC and the Board evaluate Board composition annually and identify skills, experience and capabilities desirable for new directors in light of the Company’s long-term strategy
|
|
•
The NCGC identifies potential nominees through multiple sources, including third party search firm and input from stakeholders
|
|
•
Evaluation and assessment of candidate interest, minimum qualifications, conflicts, independence, background and other information
•
Members of the NCGC, other Board members and executives meet with qualified candidates
|
|
•
NCGC recommends potential nominees to the Board for approval
•
Stockholders vote on nominees approved by Board at next annual meeting of stockholders
|
|
|
|
|
|
|
|
|
|
Character and Integrity
|
Must be an individual of the highest character and integrity
|
Leadership Experience
|
Demonstrated excellence, leadership and significant experience in their field of endeavor
|
Financial Literacy and Commitment
to Representing Stockholders |
Ability to read and understand financial statement fundamentals and commitment to representing the long-term interests of the Company’s stockholders, while keeping in perspective the interests of the Company’s customers, employees and the public
|
Independence and Constructive
Collegiality |
Must have a demonstrated ability to think and act independently as well as the ability to work constructively in a collegial environment. Must satisfy independence criteria of the SEC and NASDAQ, where independence is desired
|
Age
|
A potential director (excluding any incumbent) cannot be aged less than 21 or greater than 72 years
|
Limit on Other Public Boards
|
Independent directors – 3 (or 4 with Board approval)
CEO - 1
|
|
|
Board Roles and Responsibilities
|
|
|
|
BOARD OVERSIGHT OF RISK
The Board recognizes that effectively monitoring and managing risk are essential to the successful execution of the Company’s strategy. The Board has oversight for risk management at IPG with a focus on the most significant risks facing the Company, including strategic, operational, financial and compliance risks.
Upon recommendation of the NCGC, the Board allocates risk oversight responsibility among the full Board, the independent directors acting as a group and the three standing committees of the Board as described below. Throughout the year, the Board, the independent directors and the committees to which the Board has delegated responsibility dedicate a portion of their meetings to review and discuss specific risk topics in greater detail.
|
||
|
||
![]() |
||
|
||
AUDIT COMMITTEE
The Audit Committee oversees the policies, processes and risk relating to the financial statements, financial reporting processes, auditing, cybersecurity and compliance risks. The Audit Committee discusses with management the Company’s risk assessment and risk management practices and, when reviewing and approving the annual audit plan for the Company’s internal audit function, prioritizes audit focus areas based on their potential risk.
|
COMPENSATION COMMITTEE
The Compensation Committee oversees risk associated with management resources, including executive retention and non-CEO succession planning. It reviews the Company’s executive compensation practices, their effectiveness at linking executive pay to performance and aligning the interests of our executives and our stockholders, without encouraging excessive risk taking. The Compensation Committee annually reviews management’s assessment of compensation risk.
|
THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
The NCGC oversees risk related to the Company’s governance structure and processes, and risks arising from related person transactions. It reviews processes and risk related to Board succession planning, authority delegated to management and certain compliance risk.
|
|
|
|
![]() |
||
|
||
FULL BOARD
Our entire Board as a whole reviews risk management practices and a number of significant risks in the course of its reviews of corporate strategy, management reports and others.
|
||
|
||
![]() |
||
|
||
INDEPENDENT DIRECTORS
As a group, the independent directors oversee risks related to CEO succession planning.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Publish Annual Report and Proxy Statement. Speak with investors about topics to be addressed at the annual meeting.
|
|
|
|
|
Review results of the annual meeting, governance trends, regulatory developments. Board conducts annual self-assessment of its performance and effectiveness.
|
|
||
|
|
![]() |
|
|
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|||||
|
Consider input from investors to enhance disclosures, governance practices and compensation programs.
|
|
Communicate investor feedback to the Board. Board uses self-assessment to develop and implement changes improving effectiveness.
|
|
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board Structure
|
•
|
Chairman of the Board and Chief Executive Officer: Dr. Valentin P. Gapontsev
|
•
|
Presiding Independent Director: John R. Peeler
|
◦
|
Presiding Independent Director position is appointed annually by independent directors
|
•
|
All three Board committees composed of independent directors
|
•
|
Independent directors meet in executive session at each of the Board's in person meetings and as needed outside of regular meetings
|
•
|
setting the agenda for and leading executive sessions of the independent directors;
|
•
|
providing consolidated feedback from those meetings to the Chairman and CEO;
|
•
|
providing input on Board meeting agendas;
|
•
|
providing feedback on the quality and quantity of information flow from management;
|
•
|
calling and managing meetings of the independent directors;
|
•
|
facilitating discussions outside of scheduled Board meetings among the independent directors on key issues;
|
•
|
serving as a liaison with the Chairman and CEO;
|
•
|
interviewing Board candidates; and
|
•
|
leading the independent directors in setting the Chairman's and CEO's compensation, goals and objectives, and his annual performance evaluation.
|
•
|
the compensation committee of another entity in which one of the executive officers of such entity served on our Compensation Committee;
|
•
|
the compensation committee of another entity in which one of the executive officers of such entity served as a member of our Board; or
|
•
|
the board of directors of another entity, one of whose executive officers served on our Compensation Committee.
|
Standing Committees and Board Committee Membership
|
|
|
MEMBERS
|
FUNCTIONS:
|
Thomas J. Seifert (Chair)
Gregory P. Dougherty
Henry E. Gauthier
Catherine P. Lego
Meetings in 2019: 8
|
•
Providing oversight of financial management, the internal auditor function and the independent auditor.
•
Providing oversight with respect to our internal controls including that management is maintaining an adequate system of internal control such that there is reasonable assurance that assets are safeguarded and that financial reports are properly prepared; that there is consistent application of generally accepted accounting principles; and that there is compliance with management’s financial reporting policies and procedures.
•
Pre-approving auditing and permissible non-audit services by our independent auditor, reviewing and discussing out annual and quarterly financial statements and related disclosures, and coordinating.
•
Meeting periodically with the independent auditor, management and internal auditor function (including in private sessions) to review their work and confirm that they are properly discharging their respective responsibilities.
•
Appointing the independent auditor.
|
|
|
|
|
MEMBERS
|
FUNCTIONS:
|
Catherine P. Lego (Chair)
Gregory P. Dougherty
Eric Meurice
John R. Peeler
Meetings in 2019: 8
|
•
Reviewing and recommending to the independent directors the CEO’s base salary and opportunities for annual and long-term compensation.
•
Reviewing and approving compensation decisions recommended by the CEO for the other executive officers, including setting base salaries, annual performance bonuses, long-term incentive awards, severance benefits and perquisites.
•
Setting our compensation philosophy and composition of the group of peer companies used for comparison of executive compensation.
•
Reviewing and recommending for approval by the Board the compensation for non-employee directors.
•
Administering the equity compensation plans under which we compensate our executive officers and other key employees.
•
Retaining an independent compensation consultant firm, Radford, a unit of Aon Hewitt (“Radford”), for matters related to executive officer and director compensation, and outside legal counsel to provide advice on compensation-related matters.
•
Preparing the Compensation Committee Report included in this Proxy Statement on page
37
and overseeing management’s risk assessment of compensation for all employees and compensation-related risks as delegated by the Board.
|
|
|
|
|
MEMBERS
|
FUNCTIONS:
|
Eric Meurice (Chair)
Michael C. Child
John R. Peeler
Thomas J. Seifert
Meetings in 2019: 5
|
•
Overseeing matters of corporate governance, including the evaluation of the performance and practices of the Board.
•
Developing and recommending criteria for Board membership.
•
Reviewing possible candidates for the Board and recommending director nominees to the Board for approval.
•
Overseeing the process for the performance evaluations of the Board and its committees.
•
Engaging in Board succession planning to ensure boardroom skills are aligned with IPG’s long-term strategic plan.
•
Reviewing and recommending director orientation, stock ownership guidelines, delegation of authority to management, insider trading guidelines, and consider questions of possible conflict of interest, including related party transactions, as such questions arise.
•
Reviewing and recommending risk oversight responsibilities of the Board and its committees and of the independent directors as a group.
|
|
|
Board Practices, Policies and Processes
|
|
Board of Directors
|
Audit
|
Compensation
|
Nominating and
Corporate Governance |
Meetings held in 2019
|
6
|
8
|
8
|
5
|
Written consents in 2019
|
4
|
0
|
2
|
0
|
•
|
a majority of our Board must be independent
|
•
|
the Presiding Independent Director presides over executive sessions of independent directors
|
•
|
the Board appoints all members and chairpersons of the Board committees
|
•
|
the Audit Committee, Compensation Committee, and NCGC consist solely of independent directors
|
•
|
the independent directors meet periodically in executive sessions without the employee directors or management
|
•
|
independent directors may not serve on the boards of more than three other public companies or, with the permission of the Board, four; the CEO may not serve on more than one other public company board
|
•
|
Board self-assessments are conducted annually and
|
•
|
the Board and key officers should have a meaningful financial stake in the Company.
|
Director Compensation
|
|
Amount
|
|
|
Board Retainer
|
$
|
40,000
|
|
Presiding Independent Director Retainer
|
$
|
20,000
|
|
Audit Committee Retainers
|
|
||
Chair
|
$
|
25,000
|
|
Non-Chair
|
$
|
12,500
|
|
Compensation Committee Retainers
|
|
||
Chair
|
$
|
22,500
|
|
Non-Chair
|
$
|
10,000
|
|
Nominating and Corporate Governance Committee Retainers
|
|
||
Chair
|
$
|
17,500
|
|
Non-Chair
|
$
|
7,500
|
|
Annual Equity Award
|
$
|
250,000
|
|
Name
|
Fees Earned
or Paid in Cash ($) |
|
Stock Awards
($) (1) |
Option Awards
($) (1) |
Total
($) |
Michael C. Child
|
47,500
|
|
166,197
|
79,996
|
293,693
|
Gregory P. Dougherty
|
64,180
|
|
207,710
|
160,154
|
432,044
|
Henry E. Gauthier
|
52,500
|
|
166,197
|
79,996
|
298,693
|
Catherine P. Lego
|
75,000
|
|
166,197
|
79,996
|
321,193
|
Eric Meurice
|
67,500
|
|
166,197
|
79,996
|
313,693
|
John R. Peeler
|
77,500
|
|
166,197
|
79,996
|
323,693
|
Thomas J. Seifert
|
72,500
|
|
166,197
|
79,996
|
318,693
|
(1)
|
Valuation based on the fair value of the RSU and stock option awards as of the grant date determined pursuant to ASC Topic 718 with respect to 2019. The assumptions that we used with respect to the valuation of restricted stock unit and stock option awards are set forth in Note 12 to our Consolidated Financial Statements in our Annual Report on Form 10-K filed with the SEC on February 24, 2020. On January 23, 2019, Mr. Dougherty was elected to the Board and was granted 807 RSUs and options to purchase 2,325 shares of common stock at an exercise price of $154.88 per share, vesting on February 15, 2020. On May 30, 2019, each continuing director serving on the Board was granted 1,297 RSUs and options to purchase 1,869 shares of common stock at an exercise price of $128.46 per share, except for Mr. Dougherty, who received an award of 648 RSUs and options to purchase 934 shares of common stock, in each case reflecting proration based on the length of his Board service in 2019. The RSUs and options granted on May 30, 2020 vest in a single installment on May 28, 2020.
|
Name
|
Unvested
Restricted Stock Units (#) |
Total Option
Awards Held (#) |
Exercisable
Option Awards
(#)
|
|
Michael C. Child
|
1,297
|
43,579
|
41,710
|
|
Gregory P. Dougherty
|
1,455
|
3,259
|
—
|
|
Henry E. Gauthier
|
1,297
|
10,578
|
8,709
|
|
Catherine P. Lego
|
2,050
|
13,829
|
9,833
|
|
Eric Meurice
|
1,297
|
20,001
|
18,132
|
|
John R. Peeler
|
1,297
|
23,578
|
21,709
|
|
Thomas J. Seifert
|
1,297
|
7,677
|
5,808
|
|
•
|
Adequately compensate directors for their responsibilities and time commitments and for the personal liabilities and risks that they face as directors of a public company;
|
•
|
Attract the highest caliber non-employee directors by offering a compensation program consistent with those at companies of similar size, complexity and business character;
|
•
|
Align the interests of directors with our stockholders by providing a significant portion of compensation in equity and requiring directors to own our stock; and
|
•
|
Provide compensation that is simple and transparent to stockholders and reflects corporate governance best practices.
|
•
|
We provide cash compensation through retainers for Board and committee service, as well as additional cash retainers to the Presiding Independent Director and chairs of our standing Board committees. We do not provide Board and committee meeting fees. Compensating our directors in this manner simplifies the administration of our program and creates greater equality in rewarding service on committees of the Board. The additional retainers compensate directors for the additional responsibilities and time commitments involved with chairperson responsibilities.
|
•
|
We pay for, provide or reimburse directors for expenses, including business class travel, incurred to attend Board and committee meetings and director education programs.
|
•
|
Directors do not have a retirement plan.
|
•
|
Directors who are our employees receive no additional compensation for service on the Board.
|
|
|
|
|
|
1
|
![]() |
2
|
![]() |
3
|
The Compensation Committee engages independent compensation consultant to review compensation of non-employee directors as compared to peer group.
|
|
The Compensation Committee evaluates independent compensation consultant report, compensation trends, and need to retain and attract high caliber non-employee directors consistent with comparable companies.
|
|
The Board considers changes to non-employee directors compensation program recommended by the Compensation Committee. Approved changes generally take effect after disclosure in the proxy statement and the annual meeting of stockholders.
|
|
|
|
|
|
•
|
Non-employee directors, the lesser of 3,000 shares or three times their annual cash Board retainer (excluding committee retainers);
|
•
|
The CEO, five times his annual salary; and
|
•
|
Senior executive officers, the lesser of 5,000 shares or one times their respective annual salaries.
|
•
|
Non-employee directors, five times their annual cash Board retainer (excluding committee retainers); and
|
•
|
Senior executive officers, two times their respective annual salaries.
|
|
|
Proposal
2 |
Advisory Approval of Our Executive Compensation
|
|
|
|
The Board of Directors recommends that you vote
FOR
approval of our executive compensation.
|
|
Compensation Committee Report
|
Compensation Discussion and Analysis
|
VALENTIN P.
GAPONTSEV, PH.D. |
EUGENE
SCHERBAKOV, PH.D. |
TIMOTHY
P.V. MAMMEN |
ANGELO
P. LOPRESTI |
ALEXANDER
OVTCHINNIKOV, PH.D. |
Chairman and Chief
Executive Officer |
Chief Operating Officer, the Managing Director of IPG Laser GmbH, our subsidiary, and Senior Vice President, Europe
|
Senior Vice
President and Chief Financial Officer |
Senior Vice President,
General Counsel and Secretary |
Senior Vice President, Components
|
Stockholder Feedback
|
|
|
At our 2017 annual meeting of stockholders, our stockholders overwhelmingly approved our executive compensation structure in a “say-on-pay” advisory vote, voting 98% in favor of our executive compensation structure. As a result of the 2017 vote, the Compensation Committee determined not to change its pay philosophy or practices. Also at our annual meeting in 2017, the advisory proposal to hold “say-on-pay” advisory votes every three years received the greatest amount of votes and, therefore, we elected to submit the advisory “say-on-pay” proposal to our stockholders on a triennial basis. Accordingly, Proposal 2 is the “say-on-pay” vote.
|
![]() |
Say-on-pay approval
during last stockholder vote (2017) |
|
|
|
PRACTICES WE EMPLOY
|
|
PRACTICES WE AVOID
|
ü
Align our NEO Pay with Performance
: Strong links of compensation to Company performance and stockholder returns for annual and long term incentives. Annual bonus tied to revenue and net income and long term incentives include performance-based stock units which are earned based upon IPG’s total stockholder return relative to a broad stock market index and stock options which have value only if the stock price increases over the grant date price.
ü
Balance Annual and Long-Term Incentives
: Incentive programs provide an appropriate balance of annual and long-term incentives and include multiple measures of performance.
ü
Use Long-Term Incentives to Link Executive Pay to Company Performance
: Approximately 74% of NEO (other than the CEO) pay consists of long-term incentives linked to increasing our stock price. CEO receives no equity.
ü
Cap Incentive Award Payouts:
Annual incentive plan award payouts and certain long-term incentive awards are capped.
ü
Maximize Stockholder Value While Mitigating Risk
: Service-based equity awards vest over four years. This incentivizes long-term growth and discourages short-term risk taking.
ü
Independent Compensation Consultant
: The Compensation Committee retains a compensation consultant, who is independent and without conflicts of interest with the Company.
ü
Robust Stock Ownership Requirements
: Officers and directors are subject to stock ownership guidelines to further align their interests with stockholder interests. Our NEOs substantially exceed the ownership guidelines.
ü
Clawbacks on Executive Compensation
: We adopted a compensation recovery policy covering cash and equity.
|
|
û
No Guaranteed Annual Bonuses:
Our annual incentive compensation plan is performance-based and does not include any minimum payout levels.
û
No Retirement Benefits:
We have no supplemental executive retirement plans (SERPs) or defined benefit pension plans.
û
No Tax Gross-Ups:
We do not provide tax gross reimbursements for change in control payouts or executive perquisites.
û
No Significant Perquisites:
We provide limited perquisites to our NEOs.
û
Hedging of Company Stock is Prohibited.
û
No Severance For “Cause” Terminations.
û
No Single-Trigger Change in Control Provisions.
Equity awards for NEOs generally require a “double-trigger” of both a change-in-control and termination of employment for both cash and equity compensation acceleration.
û
No Stock Option Repricing without Stockholder Approval.
Our equity plans prohibit repricing underwater stock options.
û
Pledging of Company stock is limited.
|
2019 Compensation of Named Executive Officers
|
|
Compensation Element
|
Objective
|
|
![]() |
Base Salary
|
•
Provide a competitive fixed component of cash compensation to attract and retain talented and experienced executives with the knowledge and skills necessary to achieve the Company’s strategic business objectives
•
The Compensation Committee uses the services of an independent compensation consultant to assess the base salaries as compared to a competitive target range of the Company’s peer group
•
The Compensation Committee considers these factors when setting base salaries of the NEOs: scope of the NEO's responsibilities, contributions, skills, knowledge, experience, seniority and annual and long-term Company performance
|
|
CEO*
|
OTHER NEOs
|
||
![]() |
![]() |
||
|
* CEO receives no equity awards
|
|
|
![]() |
Annual Incentive Plan
|
•
Offer a variable cash compensation opportunity that may be earned based upon the level of achievement of challenging corporate goals, with an additional compensation opportunity based upon individual performance
•
Foster a shared commitment among executives through establishment of uniform Company financial goals
•
Award payouts are subject to a cap of 225% of target in a performance period
|
|
CEO
|
OTHER NEOs
|
||
![]() |
![]() |
||
Long-Term Incentives
|
•
Align interests of our NEOs (other than our CEO, who does not receive long-term incentive awards) and stockholders by motivating executive officers to increase long-term stockholder value
•
Service-based equity awards include stock options and RSUs. They offer certainty and long-term retention while providing additional compensation opportunity based upon increased stock price levels. Stock options further align executives with the long-term growth of stockholder value
•
Performance-based RSUs provide an additional incentive to our NEOs (other than the CEO) and are earned based on the Company's total stockholder return relative to a broad stock market index
•
Enhance retention with vesting over four years
|
||
OTHER NEOs
|
|||
![]() |
![]() |
||
Performance
based RSUs |
Service based
Equity Award |
||
|
|
||
|
401(k)
Retirement Savings Plan |
•
Provides participants the opportunity to defer a portion of their compensation and receive a company match of 50% of deferrals subject to a maximum of 6% of eligible compensation
•
The plan is available to all eligible U.S. employees
|
|
|
Pension Plan
|
•
We provide no pension plan or deferred compensation plan
|
|
|
Perquisites
|
•
Perquisites are limited
|
(1)
|
Non-GAAP “Adjusted EBIT” is an internally defined performance measure that is derived from GAAP net income by adding back the provision for income taxes, interest expense and stock-based compensation expenses and deducting interest income.
|
|
Threshold
18.75% Payout |
Target
100% Payout |
Maximum
200% Payout |
Component
Weighing (%) |
Financial Performance Award Earned (%)
|
Revenue
|
![]() |
37.5
|
0
|
||
Adjusted EBIT
|
![]() |
37.5
|
0
|
Named Executive Officer
|
Target
as a % of Base Salary (1) |
Target Award
(1)
|
Financial Performance
|
Individual Performance Maximum
|
Actual Award
|
||
Threshold
|
Target
|
Maximum
|
|||||
Valentin P. Gapontsev
|
110%
|
$1,023
|
![]() |
$256
|
$256
|
||
Eugene A. Scherbakov
|
100%
|
$679
|
![]() |
$154
|
$154
|
||
Timothy P.V. Mammen
|
80%
|
$385
|
![]() |
$96
|
$96
|
||
Angelo P. Lopresti
|
80%
|
$350
|
![]() |
$88
|
$88
|
||
Alexander Ovtchinnikov
|
80%
|
$350
|
![]() |
$88
|
$88
|
(1)
|
Target award includes both financial (weighted at 75%) and individual performance (weighted at 25%) targets. Maximum award from all performance elements limited to 225% of target. As noted above, the NEOs received payouts only with respect to individual performance for 2019.
|
Name
|
Service-Based
Stock Options (#) |
|
Exercise Price
($) |
|
Service-Based
Restricted Stock Units (#) |
|
Performance-
Based Stock Units (at Target) (#) |
|
Performance-
Based Stock Units Range (Based upon Achievement) (#) |
|
Valentin P. Gapontsev
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Eugene A. Scherbakov
|
17,908
|
|
154.88
|
|
6,214
|
|
6,214
|
|
0 - 12,428
|
|
Timothy P.V. Mammen
|
8,654
|
|
154.88
|
|
3,003
|
|
3,003
|
|
0 - 6,006
|
|
Angelo P. Lopresti
|
7,540
|
|
154.88
|
|
2,616
|
|
2,616
|
|
0 - 5,232
|
|
Alexander Ovtchinnikov
|
7,472
|
|
154.88
|
|
2,592
|
|
2,592
|
|
0 - 5,184
|
|
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2016 PSUs
|
|
|
|
|
|
|
Target TSR Index (Russell 3000
®
Index)
|
|
59.7%
|
|
|
|
|
IPG Performance
|
|
200%
|
|
|
|
|
Final 2016 Payout
|
|
125%
|
|
|
|
|
|
![]() |
|
|
|
||
2017 PSUs
|
|
|
|
|
|
|
Target TSR Index (Russell 3000
®
Index)
|
|
|
47.9%
|
|
|
|
IPG Performance
|
|
|
31.8%
|
|
|
|
Final 2017 Payout
|
|
|
67.7%
|
|
|
|
|
|
![]() |
|
|
||
2018 PSUs
|
|
|
|
|
|
|
Target TSR Index (Russell 3000
®
Index)
|
|
|
|
TBD
|
|
|
IPG Performance and Payout
|
|
|
|
TBD
|
|
|
|
|
|
![]() |
|
||
2019 PSUs
|
|
|
|
|
|
|
Target TSR Index (S&P Electronics Index)
|
|
|
|
|
TBD
|
|
IPG Performance and Payout
|
|
|
|
|
TBD
|
|
|
|
|
|
![]() |
|
|
|
Arista Networks, Inc.
|
Barnes Group, Inc.
|
Cognex Corporation
|
|
|
|
Coherent, Inc.
|
Dolby Laboratories, Inc.
|
Donaldson Company, Inc.
|
|
|
|
Entegris, Inc.
|
FLIR Systems, Inc.
|
Graco, Inc.
|
|
|
|
IDEX Corporation
|
II-VI Incorporated
|
ITT, Inc.
|
|
|
|
MKS Instruments, Inc.
|
National Instruments, Inc.
|
Nordson Corporation
|
|
|
|
Teradyne, Inc.
|
Trimble Navigation Limited
|
Waters Corporation
|
|
|
|
Zebra Technologies, Inc.
|
|
|
|
|
|
•
|
our compensation program is designed to provide a mix of both fixed and variable incentive compensation;
|
•
|
our senior executives are subject to stock ownership guidelines, which we believe incentivize our executives to consider the long-term interests of the Company and our stockholders and discourage excessive risk-taking that could negatively impact our stock price;
|
•
|
our senior executives are subject to compensation recovery policy, which discourages excessive risk-taking that could negatively affect our stock price;
|
•
|
our incentive compensation programs are designed with vesting terms that are relatively consistent, spread out over several years, and do not contain steep payout “cliffs” that might encourage short-term business decisions in order to meet a vesting or payout threshold; and
|
•
|
our senior executive incentive compensation program caps the amounts that may be paid for performance above target level.
|
Executive Compensation Tables
|
Name and Principal Position
|
Year
|
Salary
($) |
Bonus
($) |
|
Stock
Awards ($) (1) |
|
Option
Awards ($) (1) |
|
Non-Equity
Incentive Plan Compensation ($) (2) |
All Other
Compensation ($) (3) |
Total
($) |
Valentin P. Gapontsev
Chief Executive Officer and Chairman of the Board (4) |
2019
|
930,000
|
—
|
|
—
|
|
—
|
|
255,750
|
66,234
|
1,251,984
|
2018
|
1,004,585
|
—
|
|
—
|
|
—
|
|
568,000
|
50,150
|
1,622,735
|
|
2017
|
832,000
|
—
|
|
—
|
|
—
|
|
1,399,100
|
53,583
|
2,284,683
|
|
Eugene Scherbakov
Chief Operating Officer, Managing Director of IPG Laser GmbH, Senior Vice President, Europe and Director (4) |
2019
|
616,730
|
|
2,152,254
|
|
930,281
|
|
154,155
|
24,647
|
3,878,067
|
|
2018
|
673,694
|
—
|
|
2,095,549
|
|
924,421
|
|
351,800
|
23,472
|
4,068,936
|
|
2017
|
510,000
|
—
|
|
899,514
|
|
340,038
|
|
769,300
|
23,028
|
2,541,880
|
|
|
|
|
|
|
|
|
|
||||
Timothy P.V. Mammen
Chief Financial Officer and Senior Vice President |
2019
|
481,200
|
—
|
|
1,040,106
|
|
449,556
|
|
96,240
|
9,642
|
2,076,744
|
2018
|
481,200
|
—
|
|
1,012,796
|
|
446,741
|
|
213,700
|
9,060
|
2,163,497
|
|
2017
|
458,300
|
—
|
|
763,578
|
|
288,607
|
|
577,000
|
8,910
|
2,096,395
|
|
Angelo P. Lopresti
Senior Vice President, General Counsel and Secretary |
2019
|
442,100
|
|
906,066
|
|
391,686
|
|
88,420
|
10,722
|
1,838,994
|
|
2018
|
442,100
|
—
|
|
882,281
|
|
389,166
|
|
196,400
|
10,572
|
1,920,519
|
|
2017
|
421,000
|
—
|
|
623,394
|
|
235,635
|
|
530,000
|
9,342
|
1,819,371
|
|
Alexander Ovtchinnikov
Senior Vice President, Components |
2019
|
438,100
|
|
897,754
|
|
388,154
|
|
87,620
|
10,722
|
1,882,350
|
|
2018
|
438,100
|
—
|
|
873,928
|
|
385,669
|
|
194,600
|
10,572
|
1,902,869
|
|
2017
|
417,200
|
—
|
|
617,553
|
|
233,503
|
|
478,200
|
10,422
|
1,756,878
|
(1)
|
Valuation based on the fair value of such awards as of the grant date determined pursuant to Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“ASC Topic 718”). The assumptions that we used with respect to the valuation of service-based RSUs, PSUs and stock option awards are set forth in Note 12 to our Consolidated Financial Statements in our Annual Report. The amounts in the Stock Awards column reflect service-based RSUs and PSUs granted in 2019. The value of the PSUs is based on the probable outcome of the performance conditions (at the grant date) in accordance with ASC Topic 718 assuming no forfeiture. The values of PSUs at the grant date assuming the highest level of performance conditions will be achieved are $5,403,197, $2,611,169, $2,274,664 and $2,253,796 for Dr. Scherbakov, Messrs. Mammen and Lopresti and Dr. Ovtchinnikov respectively. There is no assurance that any of the performance targets will be achieved, that the service-based awards will vest or that the any of the recipients will realize the values listed above. Stock option awards and RSUs vest over four years, beginning on the first anniversary of the award date. Stock option awards have a term of ten years. PSUs cliff vest three years after start of the performance measurement period, if at all.
|
(2)
|
Represents amounts earned under our AIP for services rendered in 2019, 2018 and 2017, respectively.
|
(3)
|
The amount in 2019 for Dr. Gapontsev consists of premiums paid for group life insurance, the direct variable cost to the Company associated with a non-employee guest accompanying him on the Company’s aircraft when traveling to a specific destination for a business purpose and the expense of a automobile and driver ($49,594) provided by us for his transportation to the Company’s headquarters. The amount in 2019 for Dr. Scherbakov is the expense of an automobile provided by us.
|
(4)
|
Portions of the amounts paid to Drs. Gapontsev and Scherbakov were denominated in Euros and Rubles. Dr. Gapontsev's 2018 salary amount includes $74,585 in cash paid in lieu of accrued vacation. Dr. Scherbakov’s 2019 salary was approved in Euro. Amounts paid in foreign currencies were translated into U.S. Dollars at the average daily exchange rates for the full years. The average daily rates in 2019, 2018 and 2017, for the Euro were 0.89, 0.84 and 0.89, respectively, and for the Ruble were 64.66, 62.69 and 58.3, respectively. As a result of compensation being paid in one or more currencies that fluctuate against the U.S. Dollar, the amount of salary paid may vary slightly from the salary stated in an employment agreement or approved by the Compensation Committee.
|
Name
|
Grant
Date |
Estimated Possible Payouts
Under Non-Equity Incentive Plan Awards ($) (1) |
|
Estimated Future Payouts
Under Equity Incentive Plan Awards (#) (2) |
All Other
Stock Awards: Number of Shares of Stock or Units (#) (3) |
|
Option
Awards Number of Securities Underlying Options (#) (3) |
|
Exercise
or Base Price of Option Awards ($/Share) |
|
Grant Date
Fair Value of Stock and Option Awards ($) (4) |
|
||||||||||
Threshold
|
Target
|
Maximum
|
|
Threshold
|
Target
|
Maximum
|
||||||||||||||||
Valentin P.
Gapontsev |
2/15/2019
|
447,563
|
|
1,023,000
|
|
2,301,750
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Eugene
Scherbakov |
2/15/2019
|
269,771
|
|
616,620
|
|
1,387,395
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
3,107
|
|
6,214
|
|
12,428
|
|
—
|
|
—
|
|
—
|
|
1,195,946
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
6,214
|
|
—
|
|
—
|
|
956,308
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
17,908
|
|
154.88
|
|
930,281
|
|
|
Timothy P.V.
Mammen |
2/15/2019
|
168,420
|
|
384,960
|
|
866,160
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
1,502
|
|
3,003
|
|
6,006
|
|
—
|
|
—
|
|
—
|
|
577,957
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
3,003
|
|
—
|
|
—
|
|
462,149
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
8,654
|
|
154.88
|
|
449,556
|
|
|
Angelo P.
Lopresti |
2/15/2019
|
154,740
|
|
353,680
|
|
795,780
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
1,308
|
|
2,616
|
|
5,232
|
|
—
|
|
—
|
|
—
|
|
503,475
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
2,616
|
|
—
|
|
—
|
|
402,591
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
7,540
|
|
154.88
|
|
391,686
|
|
|
Alexander
Ovtchinnikov |
2/15/2019
|
153,335
|
|
350,480
|
|
788,580
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
1,296
|
|
2,592
|
|
5,184
|
|
—
|
|
—
|
|
—
|
|
498,856
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
2,592
|
|
—
|
|
—
|
|
398,898
|
|
|
2/15/2019
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
7,472
|
|
154.88
|
|
388,154
|
|
(1)
|
Amounts shown include possible payouts under the AIP for 2019 financial performance at the three goals plus individual performance at maximum for each. The performance goals used in determining AIP payments are discussed in
Compensation Discussion and Analysis-Annual Incentives
above. Actual amounts paid for 2019 performance are shown in the “Non-Equity Incentive Plan Compensation” column in the Summary Compensation Table above.
|
(2)
|
For a description of the PSUs, see
Compensation Discussion and Analysis-Long Term Incentives
above.
|
(3)
|
The amounts listed reflect service-based RSUs and stock options granted under our 2006 Incentive Compensation Plan and are described in the Outstanding Equity Awards Table below.
|
(4)
|
The awards are reported based on the fair value as of the grant date determined pursuant to ASC Topic 718. The assumptions that we used with respect to the valuation of equity awards are set forth in Note 12 to our Consolidated Financial Statements in our Annual Report on Form 10-K filed with the SEC on February 24, 2020. The option exercise price has not been deducted from the amounts indicated above and we disregard an estimate of forfeitures. Regardless of the value placed on an equity award on the grant date, the actual value of the equity award will depend on the market value of our common stock at such date in the future when the RSU vests or the stock option is exercised, and the performance of our common stock in relation to the S&P Composite 1500 Electronic Equipment, Instrument and Components stock index on the measurement date with respect to the PSU. For informational purposes, if the maximum level of performance were achieved for the PSUs, the values as limited by the 600% value cap are $5,403,197, $2,611,169, $2,274,664 and $2,253,796 for Dr. Scherbakov, Messrs. Mammen and Lopresti and Dr. Ovtchinnikov, respectively.
|
|
|
Option Awards
(1)
|
|
Stock Awards
(1)
|
|||||||||||||||
Name
|
Year of
Grant |
|
Securities
Underlying Unexercised Options Exercisable (#) |
|
Securities
Underlying Unexercised Options Unexercisable (#) |
|
Option
Exercise Price ($) (2) |
|
Option
Expiration Date |
|
|
Number
of Shares or Units of Stock That Have Not Vested (#) |
|
Market
Value of Shares or Units of Stock That Have Not Vested ($) (3) |
|
Equity
incentive plan awards: Number of unearned shares, units or other rights that have not vested (#) (1)(4) |
|
Equity
incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($) (4) |
|
Valentin P.
Gapontsev |
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Eugene
Scherbakov |
2/26/2010
|
|
1,000
|
|
—
|
|
15.82
|
|
2/25/2020
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
3/1/2011
|
|
3,000
|
|
—
|
|
53.76
|
|
2/28/2021
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/14/2012
|
|
1,500
|
|
—
|
|
58.65
|
|
2/13/2022
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
3/1/2013
|
|
3,000
|
|
—
|
|
60.11
|
|
2/28/2023
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/28/2014
|
|
13,000
|
|
—
|
|
71.77
|
|
2/27/2024
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/25/2015
|
|
7,326
|
|
—
|
|
97.65
|
|
2/24/2025
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/18/2016
|
|
—
|
|
7,592
|
|
81.89
|
|
2/17/2026
|
|
|
3,796
|
|
550,116
|
|
4,754
|
|
688,950
|
|
|
2/17/2017
|
|
5,184
|
|
5,183
|
|
119.50
|
|
2/16/2027
|
|
|
1,694
|
|
245,494
|
|
6,776
|
|
981,978
|
|
|
2/22/2018
|
|
3,436
|
|
10,308
|
|
239.72
|
|
2/21/2028
|
|
|
3,010
|
|
436,209
|
|
8,028
|
|
1,163,418
|
|
|
2/15/2019
|
|
—
|
|
17,908
|
|
154.88
|
|
2/14/2029
|
|
|
6,214
|
|
900,533
|
|
12,428
|
|
1,801,066
|
|
|
Timothy P.V.
Mammen |
3/1/2013
|
|
7,500
|
|
—
|
|
60.11
|
|
2/28/2023
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2/28/2014
|
|
14,200
|
|
—
|
|
71.77
|
|
2/27/2024
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/25/2015
|
|
7,362
|
|
—
|
|
97.65
|
|
2/24/2025
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/18/2016
|
|
—
|
|
7,592
|
|
81.89
|
|
2/17/2026
|
|
|
3,796
|
|
550,116
|
|
4,754
|
|
688,950
|
|
|
2/17/2017
|
|
4,400
|
|
4,399
|
|
119.50
|
|
2/26/2027
|
|
|
1,438
|
|
208,395
|
|
5,752
|
|
833,580
|
|
|
2/22/2018
|
|
1,661
|
|
4,981
|
|
239.72
|
|
2/21/2028
|
|
|
1,455
|
|
210,859
|
|
3,880
|
|
562,290
|
|
|
2/15/2019
|
|
—
|
|
8,654
|
|
154.88
|
|
2/14/2029
|
|
|
3,003
|
|
435,195
|
|
6,006
|
|
870,390
|
|
|
Angelo P.
Lopresti |
3/1/2011
|
|
9,500
|
|
—
|
|
53.76
|
|
2/28/2021
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
3/1/2013
|
|
13,000
|
|
—
|
|
60.11
|
|
2/28/2023
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/28/2014
|
|
11,000
|
|
—
|
|
71.77
|
|
2/27/2024
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/25/2015
|
|
5,661
|
|
—
|
|
97.65
|
|
2/24/2025
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/18/2016
|
|
—
|
|
5,861
|
|
81.89
|
|
2/17/2026
|
|
|
2,930
|
|
424,616
|
|
3,669
|
|
531,710
|
|
|
2/17/2017
|
|
3,592
|
|
3,592
|
|
119.50
|
|
2/16/2027
|
|
|
1,174
|
|
170,136
|
|
4,696
|
|
680,544
|
|
|
2/22/2018
|
|
1,447
|
|
4,339
|
|
239.72
|
|
2/21/2028
|
|
|
1,267
|
|
183,614
|
|
3,380
|
|
489,830
|
|
|
2/15/2019
|
|
—
|
|
7,540
|
|
154.88
|
|
2/14/2029
|
|
|
2,616
|
|
379,111
|
|
5,232
|
|
758,221
|
|
|
Alexander
Ovtchinnikov |
2/28/2014
|
|
12,000
|
|
—
|
|
71.77
|
|
2/27/2024
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2/25/2015
|
|
6,161
|
|
—
|
|
97.65
|
|
2/24/2025
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
2/18/2016
|
|
—
|
|
6,394
|
|
81.89
|
|
2/17/2026
|
|
|
3,197
|
|
463,309
|
|
4,003
|
|
580,115
|
|
|
2/17/2017
|
|
3,560
|
|
3,559
|
|
119.50
|
|
2/16/2027
|
|
|
1,163
|
|
168,542
|
|
4,652
|
|
674,168
|
|
|
2/22/2018
|
|
1,434
|
|
4,300
|
|
239.72
|
|
2/21/2028
|
|
|
1,255
|
|
181,875
|
|
3,348
|
|
485,192
|
|
|
2/15/2019
|
|
—
|
|
7,472
|
|
154.88
|
|
2/14/2029
|
|
|
2,592
|
|
375,633
|
|
5,184
|
|
751,265
|
|
(1)
|
The vesting dates assume the continued service of the NEO. All awards granted in 2016 vest in one installment on March 1, 2020. Service-based stock options and RSUs granted in 2017, 2018 and 2019 vest in four annual installments commencing on March 1, 2018, March 1, 2019 and March 1, 2020 respectively. PSUs granted in 2017, 2018 and 2019 vest in one installment on March 1, 2020, March 1, 2021 and March 1, 2022, respectively.
|
(2)
|
Represents the closing common stock price of a share on the grant date.
|
(3)
|
Based upon the closing common stock price on December 31, 2019, which was $144.92 per share.
|
(4)
|
The PSU performance measurement periods end March 1, 2020, 2021, and 2022 for units granted in 2017, 2018, and 2019, respectively. The numbers of unearned awards range from 0% to 200% based upon achievement of performance metrics and the amounts presented above assume attainment of the maximum performance levels (200%) not limited by dollar value caps. The actual payout amount for PSUs granted in 2017 which vested on March 1, 2020 was 67.7%. PSUs have dollar payout caps of 400% of target values on the dates of grant for awards granted in 2017, and 600% of target values on the date of grant for those awarded in 2018 and 2019.
|
|
Option Awards
|
|
Stock Awards
|
||||||
Name
|
Number of
Shares Acquired on Exercise (#) |
|
Value Realized
on Exercise ($) |
|
|
Number of
Shares Acquired on Vesting (#) |
|
Value Realized
on Vesting ($) (1) |
|
Valentin P. Gapontsev
|
—
|
|
—
|
|
|
—
|
|
—
|
|
Eugene A. Scherbakov
|
—
|
|
—
|
|
|
11,378
|
|
1,782,705
|
|
Timothy P.V. Mammen
|
—
|
|
—
|
|
|
10,731
|
|
1,681,333
|
|
Angelo P. Lopresti
|
—
|
|
—
|
|
|
8,373
|
|
1,311,882
|
|
Alexander Ovtchinnikov
|
—
|
|
—
|
|
|
9,011
|
|
1,411,843
|
|
(1)
|
The value realized is based on the closing common stock prices on the vesting dates of the service-based RSUs.
|
•
|
continuation of salary for eighteen months, except in the case of Dr. Gapontsev, who would receive continuation of salary for thirty-six months;
|
•
|
a portion of the annual bonus that the NEO would have received had he remained employed through the end of the applicable bonus period, based on actual performance, including the individual performance element (the portion based upon the percentage of the year that he was employed by the Company);
|
•
|
cash reimbursement for continuation of health benefits for up to eighteen months, except in the case of Dr. Gapontsev, who would receive continuation of health benefits by payment of the officer’s COBRA premiums for thirty-six-months; and
|
•
|
accelerated vesting of equity compensation awards that otherwise would have vested within twelve months of the termination of employment.
|
Name
|
Benefit
|
Termination
Without Cause or For Good Reason ($) |
|
Termination
Without Cause or For Good Reason Following a Change in Control ($) |
|
Termination
following Death ($) |
|
Termination
following Disability ($) |
|
Termination
following Non- Renewal ($) |
|
Valentin P.
Gapontsev |
Salary Severance and
Benefits Continuation |
2,835,542
|
|
2,835,542
|
|
—
|
|
—
|
|
1,890,361
|
|
Incentive Plan Severance
|
255,750
|
|
2,478,600
|
|
255,750
|
|
255,750
|
|
255,750
|
|
|
Equity Acceleration
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Total
|
3,091,292
|
|
5,314,142
|
|
255,750
|
|
255,750
|
|
2,146,111
|
|
|
Eugene A.
Scherbakov |
Salary Severance and
Benefits Continuation |
933,209
|
|
1,244,278
|
|
—
|
|
—
|
|
622,139
|
|
Incentive Plan Severance
|
169,850
|
|
1,020,020
|
|
169,850
|
|
169,850
|
|
169,850
|
|
|
Equity Acceleration
(1)
|
4,385,255
|
|
12,013,451
|
|
12,013,451
|
|
12,013,451
|
|
—
|
|
|
Total
|
5,488,314
|
|
14,277,749
|
|
12,183,301
|
|
12,183,301
|
|
791,989
|
|
|
Timothy P.V.
Mammen |
Salary Severance and
Benefits Continuation |
755,952
|
|
1,007,936
|
|
—
|
|
—
|
|
503,968
|
|
Incentive Plan Severance
|
96,240
|
|
687,533
|
|
96,240
|
|
96,240
|
|
96,240
|
|
|
Equity Acceleration
(1)
|
3,878,458
|
|
7,905,328
|
|
7,905,328
|
|
7,905,328
|
|
—
|
|
|
Total
|
4,730,650
|
|
9,600,798
|
|
8,001,568
|
|
8,001,568
|
|
600,208
|
|
|
Angelo P.
Lopresti |
Salary Severance and
Benefits Continuation |
663,150
|
|
884,200
|
|
—
|
|
—
|
|
442,100
|
|
Incentive Plan Severance
|
88,420
|
|
631,633
|
|
88,420
|
|
88,420
|
|
88,420
|
|
|
Equity Acceleration
(1)
|
3,090,177
|
|
6,538,817
|
|
6,538,817
|
|
6,538,817
|
|
—
|
|
|
Total
|
3,841,747
|
|
8,054,651
|
|
6,627,237
|
|
6,627,237
|
|
530,520
|
|
|
Alexander
Ovtchinnikov |
Salary Severance and
Benefits Continuation |
677,430
|
|
903,204
|
|
—
|
|
—
|
|
451,602
|
|
Incentive Plan Severance
|
87,620
|
|
594,567
|
|
87,620
|
|
87,620
|
|
87,620
|
|
|
Equity Acceleration
(1)
|
3,210,678
|
|
6,664,322
|
|
6,664,322
|
|
6,664,322
|
|
—
|
|
|
Total
|
3,975,702
|
|
8,162,093
|
|
6,751,942
|
|
6,751,942
|
|
539,222
|
|
(1)
|
Equity acceleration is calculated at the full value of service-based RSUs and PSUs. Also, PSUs are presented at the maximum possible amount of shares. Values use the closing common stock price on December 31, 2019, of $144.92 per share and the aggregate difference between the exercise prices of outstanding stock options and the closing common stock price on December 31, 2019.
|
|
|
Proposal
3 |
Ratify Deloitte & Touche LLP as Our Independent
Registered Public Accounting Firm for 2020 |
|
|
|
Fees
|
|||||
Fee Category
|
2019
|
|
2018
|
|
||
Audit fees
|
$
|
2,440,990
|
|
$
|
2,051,757
|
|
Audit-related fees
|
—
|
|
170,470
|
|
||
Tax fees
|
90,000
|
|
111,000
|
|
||
All other fees
|
—
|
|
—
|
|
||
Total Fees
|
$
|
2,530,990
|
|
$
|
2,333,227
|
|
|
Our Board of Directors Recommends a vote
FOR
ratification of Deloitte & Touche LLP as
our independent registered public accounting firm for 2020. |
|
Audit Committee Report
|
|
|
Proposal
4 |
Stockholder Proposal to Prepare a Report on Management Team Diversity
|
|
|
•
|
Our executive team has made improvements in making our hiring and promotion of women and minorities a priority and correspondingly the Company has attained improvement in its diversity.
|
•
|
The Company has been subject to two audits of the Office of Federal Contract Compliance Programs (A federal government office monitoring employment discrimination at government contractors), without any adverse findings.
|
•
|
We recruit and develop candidates for available leadership and other positions at the Company identifying persons from diverse backgrounds and with a variety of life experiences, including posting on national and local diversity job boards as well as partnerships with organizations, community groups and colleges that focus on the needs of minority candidates.
|
•
|
We annually send letters to our recruiters informing them of our commitment to recruit and draw from diverse pool of applicants including women and minority candidates.
|
•
|
We actively recruit at universities having higher than average populations of women and minorities in STEM (science, technology, engineering and math) related programs. Also, we support our female engineering employees in attending conferences of their peers and sponsor a female development program at a local college.
|
•
|
We maintain a “Diversity & Inclusion” microsite on our website, available under the “Our People and Communities” link on the “Our Company” page of our website, which provides potential candidates with insight into our diversity and inclusiveness initiatives as well as a view into our diverse and inclusive culture and workforce.
|
•
|
We focus on identifying persons from diverse backgrounds, skills and with a variety of life experiences as candidates for our Board as promoted by our director membership guidelines.
|
•
|
We support our diverse workforce and our commitment to an equal opportunity for all employees through a variety of methods, including a confidential ethics hotline, which promotes reporting of concerns regarding conduct that violates our Code of Business Conduct.
|
|
The Board of Directors unanimously recommends that you vote
AGAINST
this proposal.
|
|
Common Stock Ownership
|
•
|
each NEO,
|
•
|
each person who is a director or nominee,
|
•
|
all executive officers and directors as a group and
|
•
|
each person or entity known by us to own beneficially more than five percent of our common stock.
|
Named Executive Officers and Directors
(1)
|
Shares
Owned |
|
Right to Acquire
Shares within 60 Days |
|
Total
Beneficial Ownership (2) |
Percent
|
|
Michael C. Child
(3)
|
27,033
|
|
44,876
|
|
71,909
|
*
|
|
Gregory P. Dougherty
|
807
|
|
3,907
|
|
4,714
|
*
|
|
Valentin P. Gapontsev
(4)
|
7,397,642
|
|
—
|
|
7,397,642
|
13.9
|
%
|
Henry E. Gauthier
|
15,754
|
|
11,875
|
|
27,629
|
*
|
|
Catherine P. Lego
|
7,094
|
|
12,999
|
|
20,093
|
*
|
|
Angelo P. Lopresti
(5)
|
16,223,703
|
|
55,188
|
|
16,278,891
|
30.6
|
%
|
Timothy P.V. Mammen
|
35,014
|
|
48,702
|
|
83,716
|
*
|
|
Eric Meurice
|
8,268
|
|
21,298
|
|
29,566
|
*
|
|
Alexander Ovtchinnikov
(5)
|
16,260,514
|
|
34,629
|
|
16,295,143
|
30.6
|
%
|
John R. Peeler
|
7,654
|
|
24,875
|
|
32,529
|
*
|
|
Igor Samartsev
(6)(7)
|
928,066
|
|
17,788
|
|
945,854
|
1.8
|
%
|
Eugene Scherbakov
(5)(6)
|
16,203,874
|
|
54,542
|
|
16,258,416
|
30.6
|
%
|
Thomas J. Seifert
|
6,981
|
|
8,974
|
|
15,955
|
*
|
|
All executive officers and directors as a group
(15 persons) |
17,766,928
|
|
422,018
|
|
18,188,946
|
34.0
|
%
|
Other >5% Stockholders
|
|
|
|
|
|||
Valentin Gapontsev Trust I
(1)(2)(8)
|
14,542,004
|
|
—
|
|
14,542,004
|
27.4
|
%
|
IP Fibre Devices (UK) Ltd.
(1)(2)(9)
|
7,014,004
|
|
—
|
|
7,014,004
|
13.2
|
%
|
The Vanguard Group
(10)
|
3,867,440
|
|
—
|
|
3,867,440
|
7.3
|
%
|
*
|
Less than 1.0%
|
(1)
|
The contact address for each person or entity is in care of IPG Photonics Corporation, 50 Old Webster Road, Oxford, Massachusetts 01540.
|
(2)
|
In accordance with SEC rules, beneficial ownership includes any shares for which a person or entity has sole or shared voting power or investment power and any shares for which the person or entity has the right to acquire beneficial ownership within 60 days after April 1, 2020 through the exercise of any option or the vesting of a RSU or a PSU.
|
(3)
|
Includes 4,912 shares held in the name of Jewell Partners LLC, in which Mr. Child is partial owner and Managing Member.
|
(4)
|
Includes 7,014,004 shares beneficially owned by IP Fibre Devices (UK) Ltd. (“IPFD”), of which Dr. Gapontsev is the sole managing director. Dr. Gapontsev has sole voting and investment power with respect to the shares held of record by IPFD and has a 3% economic interest in IPFD. See note 9 below.
|
(5)
|
Includes (a) 7,528,000 shares owned of record by Valentin Gapontsev Trust I (“Gapontsev Trust I”), (b) 7,014,004 shares owned of record by IPFD which may be deemed to be beneficially owned by Gapontsev Trust I (see notes 8 and 9 below), (c) 692,691 shares beneficially owned by Valentin Gapontsev Trust II (“Gapontsev Trust II”), and (d) 950,250 shares beneficially owned by Valentin Gapontsev Trust III (“Gapontsev Trust III”), because such person is a trustee of each trust. Gapontsev Trust I, Gapontsev Trust II and Gapontsev Trust III were formed by CEO Valentin Gapontsev.
|
(6)
|
Each such person has an 8% economic interest in IPFD but does not possess voting or investment power with respect to such interest. Each such person disclaims beneficial ownership of the shares held by IPFD except to the extent of his economic interest therein. See note 9 below.
|
(7)
|
Includes 566,450 shares held by the spouse of Mr. Samartsev and family trusts formed by her and 10,000 shares held by the mother of Mr. Samartsev’s spouse. Mr. Samartsev disclaims beneficial ownership of such shares.
|
(8)
|
Includes 7,014,004 shares beneficially owned by IPFD, in which Gapontsev Trust I has a 48% economic interest. Gapontsev Trust I disclaims beneficial ownership of the shares held by IPFD except to the extent of its economic interest therein. See note 9 below.
|
(9)
|
Dr. Gapontsev has sole voting and investment power with respect to the shares held of record by IPFD. The following officers and directors of the Company or related parties have economic interests in IPFD: Gapontsev Trust I (48%), Dr. Gapontsev (3%), Mr. Samartsev (8%), Dr. Scherbakov (8%) and Gapontsev Trust III (2%). Each such person and entity (other than Dr. Gapontsev) does not possess voting or investment power with respect to such interest and each disclaims beneficial ownership of the shares held by IPFD except to the extent of his or its economic interest therein.
|
(10)
|
The address of The Vanguard Group is 100 Vanguard Boulevard, Malvern, PA 19355. Based solely on a Schedule 13G/A filed with the SEC on February 12, 2020.
|
Questions and Answers About the Meeting and Voting
|
WHEN:
Thursday, May 28, 2020, at 10:00 a.m. Eastern Time |
WHERE:
IPG Photonics Corporation 50 Old Webster Road Oxford, Massachusetts 01540 |
•
|
via the Internet,
|
•
|
using a toll-free telephone number,
|
•
|
completing a proxy/voting instruction card and mailing it in the postage-paid envelope provided or
|
•
|
in person at the meeting.
|
Additional Information
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Natalia Pavlova AGE: 46 DIRECTOR SINCE: 2021 COMMITTEES: Nominating and Corporate Governance Committee | |||
Kolleen Kennedy Independent Director AGE: 65 DIRECTOR SINCE: 2023 COMMITTEES: Nominating and Corporate Governance Committee (Chair) DIRECTORSHIP AT OTHER PUBLIC COMPANY: ICU Medical, Inc. | |||
John Peeler Non-Executive Chair Independent Director AGE: 70 DIRECTOR SINCE: 2012 COMMITTEES: Compensation Committee | |||
Ms. Desmond has served as a member of IPG's Board since 2021. Ms. Desmond was the Executive Vice President and Chief Financial Officer of DuPont de Nemours, Inc., a global multi-industry specialty solutions company (“DuPont”), from April 2019 to February 2020. Ms. Desmond served as Vice President and Co-Controller for DuPont from August 2017 to April 2019, and as finance leader for the Specialty Products division following the merger of DuPont with Dow Chemical. Ms. Desmond served in various leadership roles within DuPont in her 30-year career with the company. She also served on the board and was treasurer of the Delaware Prosperity Partnership, a public-private partnership overseeing economic development in Delaware from September 2017 to September 2022. Since 2020, she has served on the board of Trinseo PLC, a materials solutions provider and a manufacturer of plastics, latex binders and synthetic rubber. In October 2021, she joined the board of Sylvamo Corporation, a global producer of uncoated paper. Ms. Desmond earned a B.S. in Accounting from Mt. St. Mary’s University and is a certified public accountant (inactive). KEY ATTRIBUTES, EXPERIENCE AND SKILLS Ms. Desmond brings to the Board substantial finance and accounting experience and extensive experience in technology-driven companies. Her long management experience in a number of key strategic areas including finance leadership and operations financial planning and analysis, tax, internal audit, accounting controls, risk management, mergers and acquisitions, investor relations and public-private partnership brings depth to the skillsets of the Board. | |||
Gregory Dougherty Independent Director AGE: 65 DIRECTOR SINCE: 2019 COMMITTEES: Compensation Committee (Chair) Audit Committee DIRECTORSHIP AT OTHER PUBLIC COMPANY: MaxLinear, Inc. | |||
Gregory Beecher Independent Director AGE: 67 DIRECTOR SINCE: 2023 COMMITTEES: Audit Committee Nominating and Corporate Governance Committee | |||
Eric Meurice Independent Director AGE: 68 DIRECTOR SINCE: 2014 COMMITTEES: Nominating and Corporate Governance Committee Compensation Committee DIRECTORSHIP AT OTHER PUBLIC COMPANIES: Global Blue Group Holding AG and Intel Corporation | |||
Agnes Tang Independent Director AGE: 51 DIRECTOR SINCE: 2022 COMMITTEES: Audit Committee |
Name and Principal Position | Year |
Salary
($) |
Bonus
($) |
Stock
Awards ($) |
Non-Equity
Incentive Plan Compensation ($) |
All Other
Compensation ($) |
Total
($) |
||||||||||||||||
Mark Gitin
Chief Executive Officer |
2024 | 411,346 | 775,000 | 4,999,759 | — | 514,720 | 6,700,825 | ||||||||||||||||
Timothy Mammen
Chief Financial Officer and Senior Vice President |
2024 | 538,700 | — | 2,262,403 | 265,300 | 9,286 | 3,075,689 | ||||||||||||||||
2023 | 538,700 | — | 1,616,014 | 102,353 | 9,900 | 2,266,967 | |||||||||||||||||
2022 | 520,500 | — | 1,561,276 | 270,900 | 9,150 | 2,363,758 | |||||||||||||||||
Trevor Ness
Senior Vice President, Sales and Strategic Business Development |
2024 | 494,106 | — | 1,928,590 | 245,200 | 10,350 | 2,678,246 | ||||||||||||||||
2023 | 477,100 | — | 1,311,831 | 90,649 | 9,900 | 1,891,412 | |||||||||||||||||
Angelo Lopresti
Senior Vice President, General Counsel and Secretary |
2024 | 485,500 | — | 1,869,006 | 242,800 | 10,350 | 2,607,656 | ||||||||||||||||
2023 | 485,500 | — | 1,334,917 | 92,245 | 9,900 | 1,922,562 | |||||||||||||||||
2022 | 469,100 | — | 1,289,844 | 244,100 | 9,150 | 2,015,806 | |||||||||||||||||
Igor Samartsev
Senior Vice President, Chief Scientist |
2024 | 424,200 | — | 489,822 | 127,200 | 9,363 | 1,050,585 | ||||||||||||||||
Eugene Scherbakov
Former Chief Executive Officer |
2024 | 315,202 | — | 4,994,479 | — | 789,777 | 6,099,458 | ||||||||||||||||
2023 | 864,890 | — | 4,416,887 | 166,491 | 277,284 | 5,725,552 | |||||||||||||||||
2022 | 785,174 | — | 4,999,721 | 540,200 | 310,425 | 6,635,520 | |||||||||||||||||
Alexander Ovtchinnikov
Former Senior Vice President, Chief Technology Officer |
2024 | 371,873 | — | 1,944,416 | — | 122,114 | 2,438,403 | ||||||||||||||||
2023 | 481,000 | — | 1,322,718 | 91,390 | 9,900 | 1,905,008 | |||||||||||||||||
2022 | 464,700 | — | 1,277,805 | 241,800 | 9,150 | 1,993,455 |
Customers
Customer name | Ticker |
---|---|
Medtronic plc | MDT |
Thermo Fisher Scientific Inc. | TMO |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Valentin Gapontsev Trust I | - | 7,125,600 | 0 |
Samartsev Igor | - | 270,926 | 28,908 |
Samartsev Igor | - | 268,480 | 70,908 |
Gitin Mark Milton | - | 83,883 | 0 |
Shcherbakov Eugene A | - | 73,432 | 0 |
Shcherbakov Eugene A | - | 69,761 | 0 |
CHILD MICHAEL C | - | 68,625 | 0 |
Ovtchinnikov Alexander | - | 63,995 | 0 |
STUKALIN FELIX I | - | 31,298 | 0 |
Meurice Eric | - | 16,294 | 0 |
Burgomaster Thomas J | - | 11,566 | 0 |
Agnes Tang | - | 10,544 | 0 |
Burgomaster Thomas J | - | 8,595 | 0 |
KENNEDY KOLLEEN T | - | 2,296 | 0 |
Beecher Gregory R | - | 1,905 | 0 |